Use of clonidine in the prevention and management of neonatal abstinence syndrome

Clinical Toxicology

Volumn 47, Issue 6, 2009, Pages 551-555

  Leikin, Jerrold B ^a   MacKendrick, William P ^b   Maloney, Gerry E ^c,d   Rhee, James W ^e   Farrell, Elaine ^b   Wahl, Michael ^b   Kelly, Karen ^b  

^a Glenbrook Hospital   (United States)

^b NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^c Toxikon Consortium   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

Author keywords

Neonatal; Opioids; Withdrawal

Indexed keywords

BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CLONIDINE; FENTANYL; METHADONE; OPIATE; OXYGEN; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; HYPNOTIC SEDATIVE AGENT;

ABSENCE OF SIDE EFFECTS; ARTICLE; BIRTH WEIGHT; BRADYCARDIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; HYPOTENSION; INFANT; MALE; MEDICAL RECORD; OXYGEN SATURATION; SEDATION; SEIZURE; TREATMENT DURATION; WITHDRAWAL SYNDROME; DRUG COMBINATION; HOSPITALIZATION; NEWBORN; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADRENERGIC ALPHA-AGONISTS; CLONIDINE; DRUG THERAPY, COMBINATION; FEMALE; GESTATIONAL AGE; HUMANS; HYPNOTICS AND SEDATIVES; INFANT, NEWBORN; MALE; NEONATAL ABSTINENCE SYNDROME; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 67651165571     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650902980019     Document Type: Article

References (15)

1. Zahorodny W, Rum C, Whitney W, Giddens S, Samuel M, Maichuk G, Marshall R. The neonatal withdrawal inventory: a simplified score of newborn withdrawal. J Dev Behav Pediatr 1998; 19(2):89-93.
2. Burns L, Mattack RP. Using population data to examine the prevalence and correlates of neonatal abstinence syndrome. Drug Alcohol Rev 2007; 26(5):487-492.
3. Finnegan LP. Neonatal abstinence. In: Nelson N, ed. Current Therapy in Neonatal Perinatal Medicine. Philadelphia, PA: Mosby; 1985:262-270.
4. Sarkar S, Donn SM. Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey. J Perinatol 2006; 26(1):15-17.
5. Coyle MG, Ferguson A, Lagasse L, Oh W, Lester B. Diluted tincture of opium (DTO) and phenobarbital versus DTO alone for neonatal opiate withdrawal in term infants. J Pediatr 2002; 140(5):561-564.
6. Committee on Drugs. Neonatal drug withdrawal. Pediatrics 1998; 101(6):1079-1082.
7. Washton AM, Resnick RB. Clonidine in opiate withdrawal: review and appraisal of clinical findings. Pharmacology 1981; 1(2):140-146.
8. Kleber HD, Gold MS, Riordan CE. The use of clonidine in detoxification from opiates. Bull Narc 1980; 32(2):1-10.
9. Hoder EL, Leckman JF, Ehrenkranz R, Kleber H, Cohen DJ, Poulsen JA. Clonidine in neonatal narcotic abstinence syndrome. N Engl J Med 1981; 305(21):1284.
10. Hoder EL, Leckman JE, Poulsen J, Caruso KA, Ehrenkranz RA, Kleber HD, Cohen DJ. Clonidine treatment of neonatal narcotic abstinence syndrome. Psychiatry Res 1984; 13(3):243-251.
11. Osborn DA, Jeffrey HE, Cole MJ. Sedatives for opiate withdrawal in newborn infants. Cochrane database of systemic reviews 2005, Issue 3, Art. No. CD002053. DOI 10: 1002/1465185, 8 CD002053. pub2.
12. Pohl-Schickinger A, Lemmen J, Hubler M, Alexi-Meskishvili V, Redlin M, Berger F, Stiller B. Intravenous clonidine infusion in infants after cardiovascular surgery. Paediatr Anaesth 2008; 18:217-222.
13. Dominguez KD, Lomako DM, Katz RW, Kelly HW. Opioid withdrawal in critically ill neonates. Ann Pharmacother 2003; 37(4):473-477.
14. Franck LS, Vilardi J, Durand D, Powers R. Opioid withdrawal in neonates after continuous infusions of morphine or fentanyl during extra corporeal membrane oxygenation. Am J Crit Care 1998; 7(5):364-369.
15. Darnell CM, Thompson J, Stromberg D, Roy L, Sheeran P. Effect of low-dose infusion on fentanyl requirements in critically ill children. Pediatrics 2008; 121(5):e1363-e1371, Epub Apr 14, 2008.